PSEN2 and Alzheimer disease: These methods revealed that carriers of pathogenic mutations in APP, PSEN1, PSEN2, or APOE presented with lower neuron and higher astrocyte proportions compared to patients with sporadic AD, suggesting that the presence of AD genetic risk factors affects the cellular composition of AD brains [86].